HBIO Harvard Bioscience Inc.

Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Harvard Bioscience Inc. market cap is $192.69M.

52 week high is the highest price of a stock in the past 52 weeks, or one year. Harvard Bioscience Inc. 52 week high is $6.29 as of April 16, 2024.

52 week low is the lowest price of a stock in the past 52 weeks, or one year. Harvard Bioscience Inc. 52 week low is $3.80 as of April 16, 2024.

Harvard Bioscience Inc. stock price today is $4.44.

Harvard Bioscience Inc. stock price yesterday was $4.24.

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Harvard Bioscience Inc.’s P/E ratio is -55.36.

The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Harvard Bioscience Inc. P/B ratio is 2.6367.

EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Harvard Bioscience Inc.'s EBITDA is 30.04.

The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Harvard Bioscience Inc. 50-day moving average is $4.39.

Harvard Bioscience Inc. has 416 employees.